Abbruch

The Gynmed Team is highly engaged in further improving the laws and regulations on contraception and abortion as well as the care and medical treatment of women. To this goal we publish new insights and findings. Following please find a list of articles from medical journals written or co-authored by members of the team. The publications are in English and German.

 

  • Outcome of first trimester medical termination of pregnancy: definitions and management

    Christian Fiala, Sharon Cameron, Teresa Bombas, Mirella Parachini, Aubert Agostini, Roberto Lertxundi, Marek Lubusky, Laurence Saya & Kristina Gemzell Danielsson, 02.01.2019

    Pdf, 2.02 MBLink
  • hCG Testing to Determine Outcome after Medical Abortion: A Review

    J Preg Child Health , Christian Fiala, Teresa Bombas, Mirella Parachini, Aubert Agostini, Roberto Lertxundi, Marek Lubusky and Kristina Gemzell Danielsson, 2019

    Pdf, 679.21 KBLink
  • Early Medical Abortion - A Practical Guide For Healthcare Professionals

    Editions de Santé, Dr Christian FIALA, Pr Aubert AGOSTINI, Dr Teresa-Alexandra CARMO-BOMBAS, Pr Kristina GEMZELL-DANIELSSON, Dr Roberto LERTXUNDI, Pr Marek LUBUSKY, Dr Mirella PARACHINI, 2018

    Pdf, 1.47 MB
  • Pain management for up to 9 weeks medical abortion - An international survey among abortion providers.

    Eur J Obstet Gynecol Reprod Biol. , Fiala C, Cameron S, Bombas T, Parachini M, Agostini A, Lertxundi R, Gemzell-Danielsson K., 2018

    Pdf, 92.23 KBLink
  • Efficacy and safety of very early medical termination of pregnancy: a cohort study.

    PubMed, Bizjak I, Fiala C, Berggren L, Hognert H, Sääv I, Bring J, Gemzell-Danielsson K, 27.09.2017

    Link
  • There is no defense for ‘Conscientious objection’ in reproductive health care

    Christian Fiala, Joyce H. Arthur, July 2017

    Pdf, 510.53 KBLink
  • Assessment of pain during medical abortion with home use of misoprostol.

    PubMed, Cavet S, Fiala C, Scemama A, Partouche H, 22.06.2017

    Link
  • The dishonourable disobedience of not providing abortion.

    PubMed, Arthur J, Fiala C, Gemzell Danielsson K, Heikinheimo O, Guðmundsson JA, 22.02.2017

    Link
  • Routine misoprostol before all surgical abortions.

    PubMed, Cameron S, Fiala C, Gemzell-Danielsson K, November 2016

    Link
  • Yes we can! Successful examples of disallowing 'conscientious objection' in reproductive health care.

    Fiala C, Gemzell Danielsson K, Heikinheimo O, Guðmundsson JA, Arthur J., 03.02.2016

    Pdf, 750.07 KB
  • Medical Abortion beyond the 1st trimester

    Editions de Santé, Kristina GEMZELL-DANIELSSON, Christian FIALA,
 Aubert AGOSTINI,
 Sharon CAMERON, Teresa BOMBAS, Roberto LERTXUNDI, Marek LUBUSKY, Mirella PARACHINI, 2016

    Pdf, 6.68 MB
  • Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial.

    PubMed, Oppegaard KS, Qvigstad E, Fiala C, Heikinheimo O, Benson L, Gemzell-Danielsson K, 21.02.2015

    Link
  • Sublingual versus vaginal misoprostol for cervical dilatation 1 or 3 h prior to surgical abortion: a double-blinded RCT 


    Human Reproduction, Ingrid Saav; Helena Kopp Kallner; Christian Fiala; Kristina Gemzell-Danielsson, 2015

    Link
  • Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion.

    PubMed, Berard V, Fiala C, Cameron S, Bombas T, Parachini M, Gemzell-Danielsson K, 15.12.2014

    Link
  • Pain during medical abortion, the impact of the regimen: a neglected issue? A review.

    PubMed, Fiala C, Cameron S, Bombas T, Parachini M, Saya L, Gemzell-Danielsson K., December 2014

    Link
  • Why We Need to Ban ‘Conscientious Objection’ in Reproductive Health Care

    Joyce Arthur, Abortion Rights Coalition of Canada and Christian Fiala, Gynmed Clinic for Abortion and Family Planning, 14.05.2014

    Link
  • “Dishonourable disobedience” – Why refusal to treat in reproductive healthcare is not conscientious objection

    Christian Fiala, Joyce H. Arthur, March 2014

    Link
  • Conscientious objection and induced abortion in Europe.

    Eur J Contracept Reprod Health Care, Heino A, Gissler M, Apter D, Fiala C., August 2013

    Link
  • Is the introduction of anonymous delivery associated with a reduction of high neonaticide rates in Austria?

    BJOG, Klier CM, Grylli C, Amon S, Fiala C, Weizmann-Henelius G, Pruitt SL, Putkonen H., 05.12.2012

    Link
  • Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion

    Contraception, Kopp Kallner H, Fiala C, Gemzell-Danielsson K., 85(4):394-7., April 2012

    Link
  • Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy.

    Hum Reprod., Sioutas A, Sandström A, Fiala C, Watzer B, Schweer H, Gemzell-Danielsson K., February 2012

    Link
  • Medical abortion in lactating women - low levels of mifepristone in breast milk

    Acta Obstet Gynecol Scand., Sääv I, Fiala C,Hämäläinen JM, Heikinheimo O, Gemzell-Danielsson K., 89(5):618-22, May 2010

    Link
  • Home self administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days

    Hum Reprod., Kopp Kallner H, Fiala C, Stephansson O, Gemzell-Danielsson K., 25(5):1153-7, May 2010

    Link
  • Providing Medical Abortion in Low-Resource Settings

    Gynuity, 2009

    Pdf, 88.55 KB
  • Evaluation of Early Medical Abortion (EMA) Pilot Sites

    University of Southampton and Department of Health, London , Roger Ingham and Ellie Lee et al., 07.05.2008

    Link
  • Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy

    Int J Gynaecol Obstet., Faundes A, Fiala C, Tang OS, Velasco A., 99 Suppl 2:S172-7, December 2007

    Link
  • Misoprostol for intrauterine fetal death

    Int J Gynaecol Obstet., Gómez Ponce de León R, Wing D, Fiala C, 99 Suppl 2:S190-3, December 2007

    Link
  • Cervical priming with misoprostol prior to transcervical procedures

    Int J Gynaecol Obstet., Fiala C, Gemzell-Danielsson K., Tang OS, von Hertzen H, 99 Suppl 2:S168-71, December 2007

    Link
  • Misoprostol: first-line therapy for incomplete miscarriage in the developing world

    BJOG, Gemzell-Danielsson K, Fiala C, Weeks A., 114(11):1337-9, November 2007

    Link
  • Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol

    Hum Reprod., Aronsson A, Fiala C, Stephansson O, Granath F, Watzer B, Schweer H, Gemzell-Danielsson K., 22(7):1912-8, July 2007

    Link
  • Restricting access to safe abortion poses a serious health risk for women

    ESC newsletter, ESC, European Society of Contraception: Expert Group on abortion - C. Fiala, Austria and C. Gemzell, Sweden, June 2007

    Pdf, 438.62 KB
  • Review of medical abortion using mifepristone in combination with a prostaglandin analogue

    Contraception, Fiala C, Gemzel-Danielsson K., 74(1):66-86, July 2006

    Link
  • Frequently asked clinical questions about medical abortion

    WHO, 2006

    Pdf, 200 KBLink
  • Pharmacokinetics of a novel oral slow-release form of misoprostol

    Hum Reproduction, Fiala C, Aronsson A, Granath F, Stephansson O, Seyberth HW, Watzer B, Gemzell-Danielsson K., 20(12):3414-8, December 2005

    Link
  • The effect of non-steroidal anti-inflammatory drugs (NSAIDs) on medical abortion with mifepristone and misoprostol at 13 to 22 weeks gestation

    Human Reproduction, C. Fiala, ML. Swahn, O. Stephansson, and K. Gemzell-Danielsson, 20(11):3072-7, November 2005

    Link
  • Effects of slow release misoprostol on uterine contractility in early pregnancy

    Human Reproduction, C. Fiala, A. Aronsson, O. Stephansson and K. Gemzell-Danielsson, 20(9):2648-52., September 2005

    Link
  • Abortion in Europe: Are the Laws and Practices patient centered?

    Entre Nous magazine, UNFPA/ WHO No. 59, Christian Fiala, 23/5, 2005

    Pdf, 28.86 KB
  • Acceptability of home-use of misoprostol in medical abortion

    Contraception, Fiala C, Winikoff B, Helstrom L, Hellborg M, Gemzell-Danielsson K., 70(5):387-92., November 2004

    Link
  • Rh-prophylaxis in early abortion

    Acta Obstet Gynecol Scand., Fiala C, Fux M, Gemzell Danielsson K., 82(10):892-903. Review, October 2003

    Link
  • Verifying the effectiveness of medical abortion; ultrasound versus hCG testing

    Eur J Obstet Gynecol Reprod Biology, Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K., 109(2):190-5., 15.08.2003

    Link
  • Medical abortion - where we are in Europe

    Entre Nous magazine, UNFPA/ WHO No 47-48, Christian Fiala, 16-17, September 2000